[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"brand-tigenix":3,"geo-tigenix":-1,"alternatives-tigenix":23},{"id":4,"slug":5,"name":6,"wikidata_qid":7,"gleif_lei":8,"isin":9,"ultimate_parent_id":9,"hq_country_code":10,"hq_city":11,"founded_year":12,"official_website":13,"manufacturing_countries":9,"logo_url":9,"description":14,"is_eu_headquartered":15,"is_eu_manufactured":15,"eu_score_label":16,"attributes":17,"data_quality":18,"enriched_at":19,"created_at":20,"updated_at":21,"ownership_type":9,"stock_exchange":9,"tax_domicile":9,"ultimate_parent_name":9,"ultimate_parent_country":9,"data_hosting_country":9,"cloud_act_exposure":9,"ai_training_on_user_data":9,"dsa_designation":9,"gdpr_fines_total_eur":9,"gdpr_compliance_status":9,"supply_chain_transparency":9,"sustainable_materials":9,"carbon_neutral":9,"repair_recycling_program":9,"pays_eu_taxes":9,"eu_regulatory_fines":9,"b_corp_certified":9,"ethical_certifications":9,"ownership_disclosed":9,"annual_report_published":9,"supply_chain_audit_published":9,"timeline_events":9,"extended_enriched_at":9,"category_primary_id":9,"category_secondary_id":9,"category_confidence":22},"9d6036ec-0c89-4c3f-a964-4465bd82cfb3","tigenix","TiGenix","Q5363480","549300U4XEIPPXHC2L05",null,"BE","Madrid",2000,"http:\u002F\u002Fwww.tigenix.com","TiGenix was a Belgian biopharmaceutical company focused on developing and commercializing stem cell therapies for inflammatory and autoimmune diseases. The company was acquired by Takeda Pharmaceutical Company in 2018 and now operates as part of the Takeda group.",true,"eu_hq",{},"complete","2026-07-19T15:12:31.654+00:00","2026-07-09T06:01:16.656647+00:00","2026-07-22T16:54:24.830904+00:00",0,[]]